Solvo Biotechnology Inc.
http://www.solvobiotech.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Solvo Biotechnology Inc.
Optivia Biotechnology Inc.
Optivia Biotechnology Inc. is positioned to help drug developers address clinically significant transporter-related drug-drug interactions. In addition to its polarized mammalian cell assay, it is developing a platform for studying transporter biology and optimizing drug discovery and development.
Solvo Biotechnology Inc.
Hungarian start-up Solvo Biotechnology is attempting to create therapeutics to treat multidrug resistance--a phenomenon describing a cancer cell's ability to resist the toxicity of chemotherapies. Solvo is developing compounds targeting molecular pumps that expel cytotoxic drugs from cancerous cells.
Company Information
- Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice